Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.

Stefan Hohaus; Annalaura Di Febo; Sergio Storti; Luciana Teofili; Maria Teresa Voso; Giuseppe Leone

Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.

Stefan Hohaus, Annalaura Di Febo, Sergio Storti, Luciana Teofili, Maria Teresa Voso, Giuseppe Leone

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).

Lingua originale	English
pagine (da-a)	751-752
Numero di pagine	2
Rivista	Haematologica
Volume	89
Stato di pubblicazione	Pubblicato - 2004

Keywords

Linfoma di Hodgkin

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{b9052f61ddfa4d199d51a3bd21b186ee,

title = "Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.",

abstract = "We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).",

keywords = "Linfoma di Hodgkin, Linfoma di Hodgkin",

author = "Stefan Hohaus and {Di Febo}, Annalaura and Sergio Storti and Luciana Teofili and Voso, {Maria Teresa} and Giuseppe Leone",

year = "2004",

language = "English",

volume = "89",

pages = "751--752",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

}

TY - JOUR

T1 - Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.

AU - Hohaus, Stefan

AU - Di Febo, Annalaura

AU - Storti, Sergio

AU - Teofili, Luciana

AU - Voso, Maria Teresa

AU - Leone, Giuseppe

PY - 2004

Y1 - 2004

N2 - We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).

AB - We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).

KW - Linfoma di Hodgkin

UR - http://hdl.handle.net/10807/6337

M3 - Article

SN - 0390-6078

VL - 89

SP - 751

EP - 752

JO - Haematologica

JF - Haematologica

ER -

Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo